Benzyl isothiocyanate suppresses high-fat diet-stimulated mammary tumor progression via the alteration of tumor microenvironments in obesity-resistant BALB/c mice

Molecular Carcinogenesis

Volumn 54, Issue 1, 2015, Pages 72-82

  Kim, Minhee ^a   Cho, Han Jin ^a,f   Kwon, Gyoo Taik ^a   Kang, Young Hee ^a   Kwon, Seung Hae ^b   Her, Song ^b   Park, Taesung ^c   Kim, Yongkang ^c   Kee, Yun ^d   Park, Jung Han Yoon ^a,e  

^a Hallym University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Seoul National University   (South Korea)

^d Kangwon National University   (South Korea)

^e Seoul National University   (South Korea)

^f Seoul National University   (South Korea)

Author keywords

BITC; Cytokines; Macrophages; Mammary tumor metastasis

Indexed keywords

BENZYL ISOTHIOCYANATE; COLONY STIMULATING FACTOR 1; FAT DROPLET; MONOCYTE CHEMOTACTIC PROTEIN 1; FAT INTAKE; ISOTHIOCYANIC ACID DERIVATIVE;

3T3 CELL LINE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER CELL LINE; BREAST TUMOR; CANCER INHIBITION; CELL CYCLE PROGRESSION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE; LIPID DIET; LIPID STORAGE; LIVER METASTASIS; LUNG METASTASIS; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; CELL LINE; COMPLICATION; DRUG EFFECTS; FAT INTAKE; GENE EXPRESSION REGULATION; LIVER NEOPLASMS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; PATHOLOGY; SECONDARY;

MUS;

3T3-L1 CELLS; ANIMALS; CELL CYCLE; CELL LINE; DIETARY FATS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; ISOTHIOCYANATES; LIVER NEOPLASMS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; OBESITY; TUMOR MICROENVIRONMENT;

EID: 84914704553     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22159     Document Type: Article

References (44)

1. Steeg PS. Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 2006; 12:895-904.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30.
3. Bertucci F, Birnbaum D. Distant metastasis: Not out of reach any more. J Biol 2009; 8:28.
4. Ambrosone CB, McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 2004; 134:1134-1138.
5. Fowke JH, Chung FL, Jin F, Qi D, Cai Q, Conaway C, Cheng JR, Shu XO, Gao YT, Zheng W. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res 2003; 63:3980-3986.
6. Rao CV. Benzyl isothiocyanate: Double trouble for breast cancer cells. Cancer Prev Res (Phila) 2013; 6:760-763.
7. Conaway CC, Yang YM, Chung FL. Isothiocyanates as cancer chemopreventive agents: Their biological activities and metabolism in rodents and humans. Curr Drug Metab 2002; 3:233-255.
8. Singh SV, Singh K. Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research. Carcinogenesis 2012; 33:1833-1842.
9. Warin R, Chambers WH, Potter DM, Singh SV. Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate. Cancer Res 2009; 69:9473-9480.
10. Banka CL, Lund CV, Nguyen MT, Pakchoian AJ, Mueller BM, Eliceiri BP. Estrogen induces lung metastasis through a host compartment-specific response. Cancer Res 2006; 66:3667-3672.
11. Kim EJ, Hong JE, Eom SJ, Lee JY, Park JH. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. Breast Cancer Res Treat 2011; 130:61-71.
12. Thiebaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007; 99:451-462.
13. Kim EJ, Choi MR, Park H, Kim M, Hong JE, Lee JY, Chun HS, Lee KW, Yoon Park JH. Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res 2011; 13:R78.
14. Yan D, Avtanski D, Saxena NK, Sharma D. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires beta-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem 2012; 287:8598-8612.
15. Kim SH, Nagalingam A, Saxena NK, Singh SV, Sharma D. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis 2011; 32:359-367.
16. Yoshimura T, Howard OM, Ito T, et al. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS ONE 2013; 8:e58791.
17. Sullivan NJ, Sasser AK, Axel AE, et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009; 28:2940-2947.
18. Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011; 71:2455-2465.
19. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51.
20. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72:219-246.
21. Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 2012; 122:787-795.
22. Cho H, Jung J, Lim D, et al. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model. Breast Cancer Res 2012; 14:R81.
23. Miyoshi N, Takabayashi S, Osawa T, Nakamura Y. Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: Iimplication for prevention against inflammation-related carcinogenesis. Carcinogenesis 2004; 25:567-575.
24. Ouertatani-Sakouhi H, El-Turk F, Fauvet B, et al. A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor. Biochemistry 2009; 48:9858-9870.
25. Lee YM, Seon MR, Cho HJ, Kim JS, Park JH. Benzyl isothiocyanate exhibits anti-inflammatory effects in murine macrophages and in mouse skin. J Mol Med (Berl) 2009; 87:1251-1261.
26. Dzitoyeva S, Chen H, Manev H. 5-lipoxygenase-activating protein as a modulator of olanzapine-induced lipid accumulation in adipocyte. J Lipids 2013; 2013:864593.
27. Kim EJ, Eom SJ, Hong JE, Lee JY, Choi MS, Park JH. Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells. Mol Cell Biochem 2012; 359:431-440.
28. Park H, Kim M, Kwon GT, et al. A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice. Mol Carcinog 2012; 51:869-880.
29. Sauter BV, Martinet O, Zhang WJ, Mandeli J, Woo SL. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci U S A 2000; 97:4802-4807.
30. Kim EJ, Shin M, Park H, et al. Oral administration of 3, 3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J Nutr 2009; 139:2373-2379.
31. Cho H, Seon M, Lee Y, et al. 3, 3′-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophages. J Nutr 2008; 138:17-23.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57:289-300.
33. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19:716-723.
34. Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res 2008; 36:182-197.
35. Warin R, Xiao D, Arlotti JA, Bommareddy A, Singh SV. Inhibition of human breast cancer xenograft growth by cruciferous vegetable constituent benzyl isothiocyanate. Mol Carcinog 2010; 49:500-507.
36. Sehrawat A, Singh SV. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells. Cancer Prev Res (Phila) 2011; 4:1107-1117.
37. Spina A, Di Maiolo F, Esposito A, et al. Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells. Front Biosci (Landmark Ed) 2013; 18:133-144.
38. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-1808.
39. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112:1821-1830.
40. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol 1995; 25:64-68.
41. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116:115-124.
42. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193:727-740.
43. Mantovani A, Sica A. Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Curr Opin Immunol 2010; 22:231-237.
44. Okulicz M, Hertig I. Benzyl isothiocyanate disturbs lipid metabolism in rats in a way independent of its thyroid impact following in vivo long-term treatment and in vitro adipocytes studies. J Physiol Biochem 2013; 69:75-84.